Personalized Management of Advanced Kidney Cancer

Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Personalized peptide vaccination for advanced colorectal cancer

We have developed a novel approach in cancer immunotherapy, the personalized peptide vaccination (PPV), in which human leukocyte antigen (HLA)-matched peptides are selected on the basis of preexisting host immunity before vaccination. Recently, we demonstrated the feasibility of PPV in previously treated patients with advanced colorectal cancer, thus warranting further clinical development of t...

Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.

• History and physical examination • Laboratory tests: CBC, LDH, metabolic panel (creatinine, electrolytes, AST, ALT, alkaline phosphatase, bilirubin, INR, PTT, calcium, magnesium, phosphate, albumin), urinalysis and urine cytology • Imaging • Primary tumour i. Abdominal/pelvic CT with and without intravenous contrast ii. Abdominal MRI if CT suggests caval thrombus or because of a contrast alle...

Management of Advanced Laryngeal Cancer

Squamous cell carcinoma of the larynx continues to be the commonest head and neck cancer in many Western countries. The larynx plays a key role for many essential functions, including breathing, voice production, airway protection, and swallowing. The goals of laryngeal cancer treatment are thus to provide best possible oncologic control, while optimizing functional outcomes. In recent decades,...